Sinovac Competitors

SVA Stock  USD 6.47  0.00  0.00%   
Sinovac Biotech competes with Invivyd; as well as few others. The company runs under Biotechnology sector within Health Care industry. Analyzing Sinovac Biotech competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Sinovac Biotech to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Sinovac Biotech Correlation with its peers.
For information on how to trade Sinovac Stock refer to our How to Trade Sinovac Stock guide.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Sinovac Biotech competition on your existing holdings.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Sinovac Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
6.476.476.47
Details
Intrinsic
Valuation
LowRealHigh
6.476.476.47
Details

Sinovac Biotech Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Sinovac Biotech and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Sinovac and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Sinovac Biotech does not affect the price movement of the other competitor.

High positive correlations

IVVDITOS
SAGEITOS
RVNCITOS
BCYPITOS
YMABITOS
ORTXITOS
  

High negative correlations

CKPTGTHX
CKPTVIGL
GTHXVIGL
CKPTORTX
GTHXORTX
VIGLORTX

Risk-Adjusted Indicators

There is a big difference between Sinovac Stock performing well and Sinovac Biotech Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sinovac Biotech's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ITOS  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IVVD  5.50  0.82  0.13  0.88  5.48 
 14.95 
 46.37 
SAGE  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RVNC  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BCYP  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
YMAB  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ORTX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
VIGL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GTHX  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
CKPT  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

Sinovac Biotech Competitive Analysis

The better you understand Sinovac Biotech competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Sinovac Biotech's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Sinovac Biotech's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
SVA ITOS IVVD SAGE RVNC YMAB VIGL CKPT
 0.00 
 6.47 
Sinovac
 0.00 
 10.15 
Iteos
 11.11 
 2.60 
Invivyd
 0.00 
 8.68 
Sage
 0.00 
 3.65 
Revance
 0.00 
 8.61 
YMAB
 0.00 
 8.05 
Vigil
 0.47 
 4.26 
Checkpoint
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Target Price
Short Ratio
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Earnings To Growth
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Sinovac Biotech Competition Performance Charts

Five steps to successful analysis of Sinovac Biotech Competition

Sinovac Biotech's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Sinovac Biotech in relation to its competition. Sinovac Biotech's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Sinovac Biotech in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Sinovac Biotech's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Sinovac Biotech, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Sinovac Biotech position

In addition to having Sinovac Biotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Furniture Thematic Idea Now

Furniture
Furniture Theme
Companies producing and selling home and office furniture. The Furniture theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Sinovac Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sinovac Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sinovac Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sinovac Biotech Stock:
Check out Sinovac Biotech Correlation with its peers.
For information on how to trade Sinovac Stock refer to our How to Trade Sinovac Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sinovac Biotech. If investors know Sinovac will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sinovac Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Sinovac Biotech is measured differently than its book value, which is the value of Sinovac that is recorded on the company's balance sheet. Investors also form their own opinion of Sinovac Biotech's value that differs from its market value or its book value, called intrinsic value, which is Sinovac Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sinovac Biotech's market value can be influenced by many factors that don't directly affect Sinovac Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sinovac Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sinovac Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sinovac Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.